Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Feb 6, 2009

Premium

Aruna Biomedical announced last week that it will make its hN2 cells commercially available to the research community in early 2009.

The cells, derived from National Institutes of Health-registered human embryonic cell lines, are offered as a normal, consistent population of neural cells in an adherent monolayer format. The hN2 cells provide a human cell-based format for research ranging from Alzheimer’s disease to spinal cord injury and depression.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.